StockNews.AI
BIIB
StockNews.AI
221 days

Sage Therapeutics Confirms Receipt of Unsolicited Nonbinding Acquisition Proposal from Biogen

1. Biogen proposed to acquire Sage Therapeutics for $7.22 per share. 2. Sage's board will review the acquisition proposal carefully. 3. No guaranteed outcome from the proposal; Sage's shareholders need not act now.

3m saved
Insight
Article

FAQ

Why Bullish?

Biogen's acquisition proposal can enhance potential growth and stability for BIIB. Past proposals have led to increased interest and stock price surges.

How important is it?

The proposed acquisition directly targets BIIB's growth strategy, influencing investor sentiments and potential future valuations.

Why Short Term?

Market reactions to acquisition news typically have immediate effects on stock prices. Historical examples show short-term volatility post-announcement.

Related Companies

SAGEBIIB
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Sage Therapeutics, Inc. (Nasdaq: SAGE) (“The Company”), today confirmed that Biogen Inc. (Nasdaq: BIIB) (“Biogen”) has submitted to the Company an unsolicited, nonbinding proposal to acquire all of the outstanding shares of Sage Therapeutics not already owned by Biogen for $7.22 per share. Consistent with its fiduciary duties and in consultation with its independent financial and legal advisors, the Sage Board of Directors will carefully review and evaluate the proposal made by Biogen to determine the course of action that it believes is in the best interest of the Company and all Sage shareholders. There is no guarantee that any transaction will result from Biogen’s proposal. Sage’s shareholders do not need to take any action at this time. About Sage Therapeutics Sage Therapeutics (Nasdaq: SAGE) is a biopharmaceutical company committed to our mission of pioneering solutions to deliver life-changing brain health medicines, so every person can thrive. Sage developed the only two FDA-approved treatments indicated for postpartum depression and is advancing a pipeline to target unmet needs in brain health. Sage was founded in 2010 and is headquartered in Cambridge, Mass. Find out more at www.sagerx.com or engage with us on Facebook, LinkedIn, Instagram, and X.

Related News